Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 379 | 90 | 56 | 42 | 1 |
| Receivables | 3 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $383 | $111 | $303 | $378 | $3 |
| Non-Current Assets | |||||
| PPE Net | 7 | 1 | 16 | 32 | 43 |
| Intangibles | 3,853 | 4,500 | 0 | 0 | 0 |
| TOTAL | $3,860 | $4,501 | $16 | $32 | $43 |
| Total Assets | $4,242 | $4,612 | $319 | $409 | $46 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4 | 12 | 12 | 12 |
| Accounts payable and accrued liabilities | 157 | 144 | 4,727 | 3,990 | 3,167 |
| Accrued Expenses | 786 | 493 | N/A | N/A | N/A |
| Other current liabilities | 8,211 | 8,017 | 1,928 | 3,974 | N/A |
| TOTAL | $15,479 | $13,409 | $8,721 | $9,486 | $4,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4 | 17 | 29 |
| Other Non-Current Liabilities | 155 | 753 | 155 | 183 | 155 |
| TOTAL | $155 | $753 | $159 | $199 | $184 |
| Total Liabilities | $15,634 | $14,163 | $8,881 | $9,685 | $4,739 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 529 | 341 | 222 | N/A | N/A |
| Common Shares | 0 | 32 | 13 | 11 | 8 |
| Retained earnings | -35,620 | -29,184 | -18,374 | -13,059 | -6,293 |
| Other shareholders' equity | -1 | -2 | -2 | -2 | -2 |
| TOTAL | $-11,392 | $-9,550 | $-8,562 | $-9,276 | $-4,693 |
| Total Liabilities And Equity | $4,242 | $4,612 | $319 | $409 | $46 |